Meeting Banner
Abstract #4810

Quantification of Fructose Metabolism in Hepatocellular Carcinoma

Sui Seng Tee1, Roozbeh Eskandari2, Nathaniel Kim2, Arsen Mamakhanyan2, and Kayvan Keshari2
1Diagnostic Radiology and Nuclear Medicine, University of Maryland School of Medicine, Baltimore, MD, United States, 2Memorial Sloan Kettering Cancer Center, New York, NY, United States

Fructose metabolism utilizes a distinct set of transporters and enzymes and is limited to the liver, kidney and small intestines. Key to the ability to break down fructose is the enzyme ketohexokinase (KHK), that phosphorylates fructose to fructose-1-phosphate (F1P). In this study, we demonstrate that fructose metabolism is downregulated in a mouse model of hepatocellular carcinoma (HCC). Based on this novel observation, we use 13C nuclear magnetic resonance (NMR) to quantify altered hepatic fructose metabolism. We demonstrate significantly decreased F1P production in HCC, providing justification for developing non-invasive methods to detect fructose metabolism.

This abstract and the presentation materials are available to 2020 meeting attendees and eLibrary customers only; a login is required.

Join Here